Clinical Trial Detail

NCT ID NCT01745354
Title Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Robert Lowsky
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

SD-101

Age Groups: adult

No variant requirements are available.